Physician
Physicians for Women's Health LLC
Physicians for Women's Health LLC was paid $57.27M by Medicaid between Jan 2018 and Dec 2024, across 147 billing codes. Its largest line is 81420, Fetal chromosomal aneuploidy genomic sequence analysis panel — 10% of everything it billed.
33Billing provider infoPHYSICIANS FOR WOMEN'S HEALTH LLC
ROCKY HILL, CT 06067
ROCKY HILL, CT 06067
33aNPI1801826680assigned 07/04/2006
33bProvider typeGynecologic Oncology Physician
28Total paid$57.27M
24GClaims2,246,993
24DCodes billed147
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 235,843 | $5.10M | |
| 2019 | 281,081 | $5.65M | |
| 2020 | 278,881 | $5.77M | |
| 2021 | 365,053 | $9.05M | |
| 2022 | 355,994 | $9.70M | |
| 2023 | 373,505 | $10.56M | |
| 2024incomplete | 356,636 | $11.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 10% | 12,634 | 11,382 | $5.87M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.5% | 142,121 | 128,603 | $5.42M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.9% | 160,344 | 153,831 | $5.08M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 8.9% | 160,156 | 153,703 | $5.08M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 5.3% | 104,699 | 102,043 | $3.06M |
| 81513 | 3.7% | 23,803 | 22,464 | $2.12M | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3.4% | 140,281 | 137,026 | $1.92M |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3.1% | 33,317 | 32,338 | $1.75M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.9% | 79,914 | 76,492 | $1.68M |
| 76830 | Ultrasound, transvaginal | 2.7% | 26,892 | 25,003 | $1.52M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.6% | 22,592 | 18,282 | $1.48M |
| 87800 | 1.9% | 29,234 | 28,099 | $1.09M |
135 more codes
| 96127 | 1.7% | 63,682 | $968K | |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.6% | 16,830 | $944K |
| 86780 | 1.4% | 71,992 | $830K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.4% | 25,961 | $797K |
| 87660 | 1.3% | 45,158 | $766K | |
| 87480 | 1.3% | 45,172 | $765K | |
| 87510 | 1.3% | 44,513 | $761K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.3% | 13,025 | $759K |
| 87481 | 1.3% | 23,786 | $732K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.3% | 3,140 | $720K |
| 76801 | 1.1% | 5,492 | $655K | |
| 59025 | Fetal non-stress test | 1.1% | 13,837 | $628K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.0% | 10,568 | $594K |
| 86803 | 1.0% | 47,235 | $585K | |
| 87653 | <1% | 18,331 | $571K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 6,851 | $569K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 78,266 | $556K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 7,087 | $552K |
| 87340 | <1% | 54,646 | $491K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 7,900 | $451K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 64,330 | $435K |
| 76813 | <1% | 4,855 | $350K | |
| 86762 | <1% | 27,975 | $342K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 21,608 | $320K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 2,626 | $307K |
| 84702 | <1% | 27,350 | $284K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,531 | $283K |
| 82670 | <1% | 11,136 | $281K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 10,711 | $272K |
| 88141 | <1% | 23,202 | $241K | |
| 83001 | <1% | 14,113 | $235K | |
| 93976 | <1% | 1,718 | $210K | |
| 84146 | <1% | 10,903 | $192K | |
| 81025 | <1% | 35,008 | $184K | |
| 86696 | <1% | 10,463 | $180K | |
| 76376 | <1% | 5,425 | $151K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 17,629 | $149K |
| 87625 | <1% | 5,007 | $149K | |
| 83002 | <1% | 8,720 | $147K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 5,949 | $147K |
| 86850 | <1% | 39,357 | $129K | |
| 84144 | <1% | 6,585 | $125K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,444 | $117K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,355 | $115K |
| 87015 | <1% | 18,334 | $108K | |
| 86695 | <1% | 8,980 | $106K | |
| 82950 | <1% | 25,026 | $105K | |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 41 | $100K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,644 | $95K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 3,522 | $93K |
| 86900 | <1% | 34,541 | $88K | |
| 86901 | <1% | 34,209 | $87K | |
| 87077 | <1% | 11,466 | $83K | |
| 87088 | <1% | 11,408 | $83K | |
| 82627 | <1% | 4,013 | $82K | |
| 82951 | <1% | 7,299 | $81K | |
| 86787 | <1% | 6,844 | $75K | |
| 84439 | <1% | 9,286 | $73K | |
| 85027 | <1% | 11,602 | $67K | |
| 88142 | <1% | 4,443 | $61K | |
| 80053 | Comprehensive metabolic panel | <1% | 5,455 | $51K |
| 82607 | <1% | 3,397 | $46K | |
| 80050 | General health panel | <1% | 1,291 | $46K |
| 99385 | <1% | 738 | $45K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,873 | $37K |
| 99459 | <1% | 2,693 | $33K | |
| 82728 | <1% | 2,563 | $32K | |
| 82746 | <1% | 2,229 | $30K | |
| 80061 | Lipid panel | <1% | 2,455 | $30K |
| 59514 | <1% | 51 | $27K | |
| 83525 | <1% | 2,568 | $27K | |
| 87147 | <1% | 5,471 | $26K | |
| 82952 | <1% | 5,847 | $20K | |
| 87186 | <1% | 2,316 | $18K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 169 | $16K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 848 | $16K |
| 84703 | <1% | 2,350 | $16K | |
| 93975 | <1% | 105 | $16K | |
| 86304 | <1% | 841 | $16K | |
| 80076 | <1% | 1,932 | $14K | |
| 88344 | <1% | 198 | $14K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 188 | $14K |
| 99234 | <1% | 174 | $13K | |
| 99404 | <1% | 157 | $10K | |
| 82947 | <1% | 2,830 | $10K | |
| 87210 | <1% | 1,709 | $9K | |
| 76857 | <1% | 184 | $8K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 140 | $8K |
| 84550 | <1% | 3,455 | $7K | |
| 90651 | <1% | 29 | $7K | |
| 80305 | <1% | 976 | $7K | |
| 97810 | <1% | 581 | $6K | |
| 81002 | <1% | 57,159 | $5K | |
| 84450 | <1% | 3,083 | $5K | |
| 36416 | <1% | 1,719 | $5K | |
| 90686 | <1% | 343 | $5K | |
| 82565 | <1% | 2,526 | $5K | |
| 82272 | <1% | 1,633 | $5K | |
| 84460 | <1% | 3,094 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,420 | $4K |
| 82270 | <1% | 1,467 | $4K | |
| 90674 | <1% | 197 | $4K | |
| 83986 | <1% | 1,458 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 513 | $4K |
| 82120 | <1% | 1,322 | $4K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,348 | $4K |
| 76641 | <1% | 45 | $3K | |
| 76818 | <1% | 31 | $3K | |
| 88307 | <1% | 51 | $3K | |
| 83615 | <1% | 1,325 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 569 | $3K |
| 87184 | <1% | 421 | $3K | |
| 84520 | <1% | 2,113 | $3K | |
| 99235 | <1% | 25 | $3K | |
| 85018 | <1% | 2,366 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 45 | $2K |
| 88112 | <1% | 26 | $2K | |
| 90656 | <1% | 112 | $2K | |
| 99442 | <1% | 30 | $1K | |
| 81003 | <1% | 3,395 | $682.33 | |
| 54150 | <1% | 14 | $626.40 | |
| 58300 | <1% | 14 | $592.41 | |
| 96040 | <1% | 15 | $344.25 | |
| 90688 | <1% | 22 | $338.96 | |
| 51798 | <1% | 43 | $249.42 | |
| 88304 | <1% | 15 | $164.23 | |
| 82274 | <1% | 12 | $149.64 | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 50 | $101.10 |
| 82248 | <1% | 40 | $91.67 | |
| 81000 | <1% | 41 | $87.04 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 25 | $48.42 |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 31 | $5.38 |
| 7025F | 0% | 860 | $0.00 | |
| A4550 | Surgical trays | 0% | 29 | $0.00 |
| 0502F | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOTTSCHALL, DANIEL (CHIEF MEDICAL OFFICER)